双鹭药业(002038.SZ)：上半年净利润1.21亿元 同比增长309.08%

Core Viewpoint - 双鹭药业 reported a significant decline in revenue while achieving substantial growth in net profit, indicating a mixed financial performance for the first half of 2025 [1] Financial Performance - The company achieved an operating revenue of 305 million yuan, representing a year-on-year decrease of 22.24% [1] - The net profit attributable to shareholders reached 121 million yuan, showing a year-on-year increase of 309.08% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 26.0044 million yuan, reflecting a year-on-year decline of 78.42% [1] - Basic earnings per share were reported at 0.12 yuan [1]